LONDON, December 17 /PRNewswire/ -- Misys plc (FTSE: MSY.L), the global application software and services company, today announces that it had been selected by UBI Banca International to help consolidate its international business. The Misys solution will enable the bank to improve efficiencies and business management across the group and ensure a consistent level of service to customers in Luxembourg, Spain and Germany.

CHICAGO and LONDON, December 17 /PRNewswire/ --

- Clients gain point-click access to European equity algorithms through simple pull-down menu

Townsend Analytics (www.taltrade.com), a leading provider of multi-broker, multi-asset, multi-region and multi-route electronic trading solutions for the global capital markets, has integrated equity algorithms from leading European broker Cheuvreux into Townsend's flagship Execution Management System (EMS), RealTick(R).

PLANEGG-MARTINSRIED, Germany, December 17 /PRNewswire/ -- The Management Board and the Supervisory Board of the drug discovery and development company 4SC AG (Frankfurt, Prime Standard: VSC), with its headquarters in Martinsried, Germany, today published their joint statement on the public mandatory offer of Santo Holding (Deutschland) GmbH pursuant to Section 27 (1) of the German Securities Acquisition and Takeover Act (WpÜG).

LONDON, December 17 /PRNewswire/ --

- Upgrades to Mippin Made in Line With Consumer Demand

Mippin, the free mobile web discovery service from Refresh Mobile, which connects you to your favourite web content on the phone, has revealed their users top handsets for accessing the mobile internet in the run up to this Christmas this year. Nokia is the most popular and accounts for over 50% of all Mippin.com access, whilst the iPhone is showing great momentum, already breaking into the US top 10 Mippin handsets. The Motorola RAZR, KRZR are also proving popular.

The Top 5 handsets with Mippin users by country:

OXFORD, England, December 17 /PRNewswire/ --

- New Deal Provides a Further Opportunity for OGeS to Grow its Therapeutic Antibody Pipeline

Oxford Genome Sciences (UK) Ltd "OGeS" announces today that it has entered into a strategic collaboration with Amgen to discover, develop and commercialise novel therapeutic antibodies for the treatment of cancer. This new collaboration will enable OGeS to further strengthen its pipeline of fully human therapeutic antibodies (mAbs) in cancer based on the target discovery capabilities of its unique OGAP(R) database.

LEIDEN, The Netherlands, December 17 /PRNewswire/ --

- Researchers Expect Groundbreaking Results

Today Top Institute Pharma presents a new and highly promising research project. The TI Pharma project is a large-scale study into the brain material of Alzheimer's and Parkinson's patients, who gave permission to the Netherlands Brain Bank for their tissue to be used for scientific research. The analysis is a continuation of highly-promising results from previous studies and focuses on the genes that could be involved in the development of Alzheimer's disease and Parkinson's disease. The study - that must form the basis for potential drugs - is one of the largest to be carried out on an international level.

The brain remains a complicated machine but researchers from the Center for the Neural Basis of Cognition (CNBC), a joint project of Carnegie Mellon University and the University of Pittsburgh have made progress in explaining why, when we notice a scent, the brain can quickly sort through input and determine exactly what that smell is.

To do it, they created a biologically inspired algorithm for analyzing the brain at work and they have described a mechanism called “dynamic connectivity,” in which neuronal circuits are rewired “on the fly” allowing stimuli to be more keenly sensed.

“If you think of the brain like a computer, then the connections between neurons are like the software that the brain is running.

About 10 years ago, a UC San Diego psychology professor named Ben Williams, who is in my area of psychology (animal learning), managed to successfully cure his own terminal cancer by self-experimentation. He wrote a book about it called Surviving Terminal Cancer. As this WSJ story shows, his approach — which can be summed up think for yourself — is spreading.

Researchers of the Institute of Molecular Biology, Russian Academy of Sciences, have been working for more than 20 years on designing biological microchips for efficient and quick diagnostics of tuberculosis and other diseases.

The BIOCHIP-IMB company was set up at the Institute for production of domestic microchips. During the press-tour on November 15, 2007, the researchers told journalists about progress and achievements. The project of the laboratory of biological microchips at the Institute of Molecular Biology (Russian Academy of Sciences ) is one of the winners at the contest of projects on the “Living Systems” priority direction of the Federal Target Program guided by the Federal Agency for Science and Innovations (Rosnauka).

Today, people from all over the world are insufficiently aware about their daily food consumption. Most like to eat organic food and reduce GM (Genetically Modified) crops. So farmers of both modern and developing countries are trying to produce organic crops. But at this time there are lots of pests and insects which decrease the yield of crops and losses total yields. For this reason farmers are interested in cultivating their crops under Integrated Pest Management and other control management systems. If they want to produce crops without the help of synthetic insecticides, they can use organic pesticides such as neem (Azadirachta indica) plant extract.